Literature DB >> 15378200

Self and non-self discrimination is needed for the existence rather than deletion of autoimmunity: the role of regulatory T cells in protective autoimmunity.

M Schwartz1, J Kipnis.   

Abstract

Autoimmune T cells have been viewed for decades as an outcome of immune system malfunction, and specifically as a failure to distinguish between components of self and non-self. The need for discrimination between self and non-self as a way to avoid autoimmunity has been repeatedly debated over the years. Recent studies suggest that autoimmunity, at least in the nervous system, is the body's defense mechanism against deviations from the normal. The ability to harness neuroprotective autoimmunity upon need is evidently allowed by naturally occurring CD4+CD25+ regulatory T cells, which are themselves controlled by brain-derived compounds. These findings challenge widely accepted concepts of the need for discrimination between self and non-self, as they suggest that while such discrimination is indeed required, it is needed not as a way to avoid an anti-self response but to ensure its proper regulation. Whereas a response to non-self can be self-limited by a decreased presence of the relevant antigen, the response to self needs a mechanism for strict control, such as that provided by the naturally occurring regulatory T cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15378200     DOI: 10.1007/s00018-004-4233-6

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  40 in total

Review 1.  Left ventricular noncompaction: a 25-year odyssey.

Authors:  Timothy E Paterick; Matt M Umland; M Fuad Jan; Khawaja Afzal Ammar; Christopher Kramer; Bijoy K Khandheria; James B Seward; A Jamil Tajik
Journal:  J Am Soc Echocardiogr       Date:  2012-01-27       Impact factor: 5.251

Review 2.  Left ventricular non-compaction revisited: a distinct phenotype with genetic heterogeneity?

Authors:  Erwin Oechslin; Rolf Jenni
Journal:  Eur Heart J       Date:  2011-01-31       Impact factor: 29.983

3.  Wide spectrum of presentation and variable outcomes of isolated left ventricular non-compaction.

Authors:  C Lofiego; E Biagini; F Pasquale; M Ferlito; G Rocchi; E Perugini; L Bacchi-Reggiani; G Boriani; O Leone; K Caliskan; F J ten Cate; F M Picchio; A Branzi; C Rapezzi
Journal:  Heart       Date:  2006-04-27       Impact factor: 5.994

4.  Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention.

Authors:  Barry J Maron; Jeffrey A Towbin; Gaetano Thiene; Charles Antzelevitch; Domenico Corrado; Donna Arnett; Arthur J Moss; Christine E Seidman; James B Young
Journal:  Circulation       Date:  2006-03-27       Impact factor: 29.690

5.  Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases.

Authors:  Perry Elliott; Bert Andersson; Eloisa Arbustini; Zofia Bilinska; Franco Cecchi; Philippe Charron; Olivier Dubourg; Uwe Kühl; Bernhard Maisch; William J McKenna; Lorenzo Monserrat; Sabine Pankuweit; Claudio Rapezzi; Petar Seferovic; Luigi Tavazzi; Andre Keren
Journal:  Eur Heart J       Date:  2007-10-04       Impact factor: 29.983

6.  Mutations in sarcomere protein genes in left ventricular noncompaction.

Authors:  Sabine Klaassen; Susanne Probst; Erwin Oechslin; Brenda Gerull; Gregor Krings; Pia Schuler; Matthias Greutmann; David Hürlimann; Mustafa Yegitbasi; Lucia Pons; Michael Gramlich; Jörg-Detlef Drenckhahn; Arnd Heuser; Felix Berger; Rolf Jenni; Ludwig Thierfelder
Journal:  Circulation       Date:  2008-05-27       Impact factor: 29.690

Review 7.  Genetic testing in cardiovascular disease.

Authors:  Nathaniel H Robin; Paul B Tabereaux; Raymond Benza; Bruce R Korf
Journal:  J Am Coll Cardiol       Date:  2007-08-06       Impact factor: 24.094

Review 8.  Isolated noncompaction of the left ventricular myocardium -- a review of the literature two decades after the initial case description.

Authors:  R Engberding; T M Yelbuz; G Breithardt
Journal:  Clin Res Cardiol       Date:  2007-06-04       Impact factor: 5.460

9.  Isolated left ventricular noncompaction syndrome.

Authors:  Christopher Stanton; Charles Bruce; Heidi Connolly; Peter Brady; Imran Syed; David Hodge; Samuel Asirvatham; Paul Friedman
Journal:  Am J Cardiol       Date:  2009-08-28       Impact factor: 2.778

10.  Genetic evaluation of cardiomyopathy--a Heart Failure Society of America practice guideline.

Authors:  Ray E Hershberger; Joann Lindenfeld; Luisa Mestroni; Christine E Seidman; Matthew R G Taylor; Jeffrey A Towbin
Journal:  J Card Fail       Date:  2009-03       Impact factor: 5.712

View more
  5 in total

1.  Increased CD4+ CD25+ T regulatory cell activity in trauma patients depresses protective Th1 immunity.

Authors:  Malcolm P MacConmara; Adrian A Maung; Satoshi Fujimi; Ann M McKenna; Adam Delisle; Peter H Lapchak; Selwyn Rogers; James A Lederer; John A Mannick
Journal:  Ann Surg       Date:  2006-10       Impact factor: 12.969

Review 2.  Transient immunosuppression: a bridge between infection and the atypical autoimmunity of Guillain-Barré syndrome?

Authors:  I Steiner; G Rosenberg; I Wirguin
Journal:  Clin Exp Immunol       Date:  2010-10       Impact factor: 4.330

Review 3.  Controlled autoimmunity in CNS maintenance and repair: naturally occurring CD4+CD25+ regulatory T-Cells at the crossroads of health and disease.

Authors:  Jonathan Kipnis; Michal Schwartz
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

Review 4.  Mononuclear phagocytes in the pathogenesis of neurodegenerative diseases.

Authors:  I Kadiu; J G Glanzer; J Kipnis; H E Gendelman; M P Thomas
Journal:  Neurotox Res       Date:  2005-10       Impact factor: 3.911

Review 5.  Does inflammation in an autoimmune disease differ from inflammation in neurodegenerative diseases? Possible implications for therapy.

Authors:  Michal Schwartz; Oleg Butovsky; Jonathan Kipnis
Journal:  J Neuroimmune Pharmacol       Date:  2006-03       Impact factor: 7.285

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.